SynAct Pharma AB
559058-4826ActiveClinical-stage biotech resolving inflammation via novel oral therapies.
Yleiskatsaus
- 5–9
- Työntekijät
- 5–10milj SEK
- Liikevaihto
- 2016
- Perustettu
Avainpäättäjät
Ann Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
SynAct Pharma is a clinical-stage biotechnology company dedicated to developing innovative medicines. Its core scientific approach centers on "Resolution Therapy," aiming to actively resolve ongoing inflammatory processes rather than merely inhibiting them. This strategy seeks to restore immune bala...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559058482601
Päättäjät
22 yhteystietoa FunnelfeedrissäAnn Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
Mauro Perretti
Advisory Board Member
Björn Westberg
Chief Financial Officer
Malin Wikstrand
Interim Chief Financial Officer
Jeppe Ragnar Andersen
Board Member
Thomas Boesen, PhD.
Chief Operating Officer
Sten Sørensen
Board Member
Thomas Boesen
Chief Operating Officer
Thomas Jonassen, MD.
Chief Scientific Officer
James Knight
Advisory Board Member
Vibeke Strand
Advisory Board Member
Thomas Jonassen
Chief Scientific Officer
Sten Scheibye
Board Member
Mads Bjerregaard
Chief Business Officer
Kirsten Harting
Chief Medical Officer
Sten Sörensen
Board Member
Anders Kronborg
Chairman of the Board
Torbjørn Bjerke
Chief Executive Officer
Mauro Teixeira
Advisory Board Member
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäSynartro AB
1–4 työntekijätDeveloping sustained local injection treatments for osteoarthritis pain relief.
Pharmnovo Aktiebolag
1–4 työntekijätDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Sangair AB
3 työntekijätDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Novakand Pharma AB
5–9 työntekijätDeveloping novel small-molecule drugs for inflammation and cancer.
PILA PHARMA AB
1–4 työntekijätClinical stage biotech developing an oral obesity and diabetes treatment.
Selaa lisää
Kysymyksiä yrityksestä SynAct Pharma AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo